Dudediligence.

Harrow, Inc

HROWNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$275.6Mlast 12 months
Net income
−$37.2Mlast 12 months
Operating cash flow
$15.2Mlast 12 months
Cash and equivalents
$83.9Mat the last balance sheet
Total debt
$300.0Mat the last balance sheet
Shares outstanding
37.5M shareson issue
Every year and quarter →